In this episode of The Dales Report Psychedelic Exclusive, we have the opportunity to sit down with Setti Coscarella, Vice President of Corporate Affairs, and Ronan Levy, an advisor, from Safe Supply. We explore the promising potential of the psychedelics industry and the exciting business opportunities it offers. We share our perspective on the market outlook for psychedelics in the coming years, highlighting the potential for growth and social impact.
We will discuss the interplay between drug policy and the psychedelics industry, emphasizing the need for a compassionate approach to address substance abuse issues. This highlights the importance of collaboration with governments to develop policies that support safe supply and harm reduction measures. We also touch upon the positive impact of decriminalization models, exemplified by Portugal's approach, which has led to reduced crime rates and improved outcomes for individuals struggling with addiction.
An examination of investment opportunities in the psychedelics industry is presented, with a focus on understanding government policies and engaging in meaningful dialogue to support their successful implementation. The video discusses the potential for psychedelics, such as MDMA and psilocybin, as therapeutic treatments for conditions like PTSD. It also highlights the transformative impact of recent regulatory shifts, such as the rescheduling of cannabis, and the resulting opportunities for growth and investment in the sector.
Join us as we discover the potential for growth and the business possibilities that lie ahead in this rapidly developing industry, driven by advancements in research, changing attitudes, and government initiatives.
IHL Price at posting:
6.8¢ Sentiment: Buy Disclosure: Held
